These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 10433563

  • 21. [Frequency, risk factors and prognostic value of anemia associated with HIV/AIDS in the adult in Mali].
    Diallo DA, Baby M, Dembélé M, Kéita A, Sidibé AT, Cissé IA, Diop CT, Maïga II, Traoré AK, Traoré HA.
    Bull Soc Pathol Exot; 2003 May; 96(2):123-7. PubMed ID: 12836531
    [Abstract] [Full Text] [Related]

  • 22. Recombinant human erythropoietin: has treatment reached its full potential?
    Fishbane S.
    Semin Dial; 2006 May; 19(1):1-4. PubMed ID: 16423172
    [Abstract] [Full Text] [Related]

  • 23. Erythropoietin (r-HuEPO) in the treatment of anemia of nodular sclerosis type Hodgkin's disease--a preliminary report.
    Wojtukiewicz MZ, Sawicki Z, Radziwon P.
    Rocz Akad Med Bialymst; 2000 May; 45():145-9. PubMed ID: 11712426
    [Abstract] [Full Text] [Related]

  • 24. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
    Desai J, Demetri GD.
    Best Pract Res Clin Haematol; 2005 May; 18(3):389-406. PubMed ID: 15792913
    [Abstract] [Full Text] [Related]

  • 25. Anemia and survival in human immunodeficiency virus.
    Lundgren JD, Mocroft A.
    Clin Infect Dis; 2003 May; 37 Suppl 4():S297-303. PubMed ID: 14581998
    [Abstract] [Full Text] [Related]

  • 26. Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia.
    Sipsas NV, Kokori SI, Ioannidis JP, Kyriaki D, Tzioufas AG, Kordossis T.
    J Infect Dis; 1999 Dec; 180(6):2044-7. PubMed ID: 10558967
    [Abstract] [Full Text] [Related]

  • 27. [Indications and limits of recombinant human erythropoietin in intensive care unit].
    Ventré C, Rousseau S, Albanèse J, Leone M, Martin C.
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):714-21. PubMed ID: 15324960
    [Abstract] [Full Text] [Related]

  • 28. The impact of anemia on quality of life in human immunodeficiency virus-infected patients.
    Volberding P.
    J Infect Dis; 2002 May 15; 185 Suppl 2():S110-4. PubMed ID: 12001031
    [Abstract] [Full Text] [Related]

  • 29. Epoetin beta therapy in patients with solid tumours.
    Pronzato P, Jassem J, Mayordomo J.
    Crit Rev Oncol Hematol; 2006 Apr 15; 58(1):46-52. PubMed ID: 16169242
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.
    Crit Care Med; 2006 Sep 15; 34(9):2310-6. PubMed ID: 16878035
    [Abstract] [Full Text] [Related]

  • 31. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR, Gentile M, Foa R.
    Rev Clin Exp Hematol; 2002 Sep 15; Suppl 1():21-31. PubMed ID: 12735212
    [Abstract] [Full Text] [Related]

  • 32. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E, Rossi E, Clavio M, Congiu A, Gobbi M, Grosso M, Secondo V, Spriano M, Timitilli S, Ghio R.
    Ann Hematol; 2006 Mar 15; 85(3):174-80. PubMed ID: 16408206
    [Abstract] [Full Text] [Related]

  • 33. Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.
    Pangalis GA, Siakantaris MP, Angelopoulou MK, Vassilakopoulos TP, Dimopoulou MN, Kyrtsonis MC, Konstantopoulos K, Tsaftaridis P, Vaiopoulos GA, Kontopidou FN.
    Haematologica; 2002 May 15; 87(5):500-6. PubMed ID: 12010663
    [Abstract] [Full Text] [Related]

  • 34. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC, Clausen NT, Jensen BA.
    Am J Hematol; 2002 Jun 15; 70(2):92-9. PubMed ID: 12111781
    [Abstract] [Full Text] [Related]

  • 35. Anemia in multiple myeloma.
    Ludwig H, Pohl G, Osterborg A.
    Clin Adv Hematol Oncol; 2004 Apr 15; 2(4):233-41. PubMed ID: 16163188
    [Abstract] [Full Text] [Related]

  • 36. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
    Baron F, Frère P, Fillet G, Beguin Y.
    Clin Cancer Res; 2003 Nov 15; 9(15):5566-72. PubMed ID: 14654537
    [Abstract] [Full Text] [Related]

  • 37. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
    Keast DH, Fraser C.
    Ostomy Wound Manage; 2004 Oct 15; 50(10):64-70. PubMed ID: 15509883
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
    Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH.
    Laryngoscope; 2002 Jul 15; 112(7 Pt 1):1221-9. PubMed ID: 12169903
    [Abstract] [Full Text] [Related]

  • 40. Anemia in critical illness.
    Eckardt KU.
    Wien Klin Wochenschr; 2001 Feb 15; 113(3-4):84-9. PubMed ID: 11253745
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.